Barclays Maintains Overweight on ChampionX, Raises Price Target to $51
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst David Anderson has maintained an Overweight rating on ChampionX (NASDAQ:CHX) and increased the price target from $39 to $51.
April 04, 2024 | 2:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays analyst David Anderson has reaffirmed an Overweight rating on ChampionX and raised the price target from $39 to $51.
The increase in price target by a reputable analyst suggests a strong confidence in ChampionX's future performance. This is likely to positively influence investor sentiment and potentially lead to a short-term increase in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100